<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0005048'>Thrombosis</z:mp> is a rare complication in patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> because of the presence of coincidental <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have recently treated two cases, a 61-year-old male and a 59-year-old female, with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> associated with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Although their platelet counts were lower than <z:mpath ids='MPATH_458'>normal</z:mpath> in spite of treatment with <z:e sem="disease" ids="C1456831" disease_type="Mental or Behavioral Dysfunction" abbrv="">anabolic steroids</z:e> for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, the coronary angiographic findings strongly suggested coronary <z:mp ids='MP_0005048'>thrombosis</z:mp> in both cases </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1456831" disease_type="Mental or Behavioral Dysfunction" abbrv="">Anabolic steroids</z:e>, which have been commonly used for the treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, are a possible risk factor for coronary <z:mp ids='MP_0005048'>thrombosis</z:mp> because they have an accelerating effect on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="4" pm="."><plain>We report two very rare but clinically important cases </plain></SENT>
</text></document>